Exhaled Bioaerosols from Asymptomatic COVID-19 carriers - A Potential Risk in Orthodontics?

Inhaling to mitigate exhaled bioaerosols.

Humans commonly exhale aerosols comprised of small droplets of airway-lining fluid during normal breathing. These "exhaled bioaerosols" may carry airborne pathogens and thereby magnify the spread of certain infectious diseases, such as influenza, tuberculosis, and severe acute respiratory syndrome. We hypothesize that, by altering lung airway surface properties through an inhaled nontoxic aeros...

Therapeutic potential of Paclitaxel against COVID-19

The coronavirus disease-2019(COVID-19) was reported in Wuhan, China, in late December 2019 and soon became the most serious global health challenge due to high rate of human-to-human transmission. The severe acute respiratory syndrome coronavirus 2(SARS-CoV-2), is a single-stranded RNA virus and belongs to the large Coronaviridae family. Paclitaxel, an antineoplastic drug extracted from the Tax...

COVID-19: A New Virus as a Potential Rapidly Spreading in the Worldwide

Covid-19 is a novel virus with high affinity to spread in the community. In December 2019, it was first identified in Wuhan, China. The symptoms are non-specific, so fever, cough, dyspnea, are prominent features. Respiratory failure and mortality have also been reported. The most common lung CT scan findings are bilateral ground glass opacities.

Developing a Method for Assessing and Managing the Risk of Covid-19; Rapid Covid-19 Hazard analysis

Background and aims: Work environments are constantly changing under the influence of various factors and newer risks are introduced. Rapid changes in science and technology, increasing the complexity of the industry, increased system integration and other factors have been shown to increase total risk in the past few decades. As well, risk management becomes increasingly critical in decreasing...

COVID-19 Risk Perception and its Related Factors and Outcomes in Vulnerable Groups: A Systematic Review